Clinical Trials Logo

Esophageal and Gastric Varices clinical trials

View clinical trials related to Esophageal and Gastric Varices.

Filter by:

NCT ID: NCT02311608 Recruiting - Liver Cirrhosis Clinical Trials

Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails

CER:T
Start date: February 2014
Phase: N/A
Study type: Observational

To observe and access the Effects and safety of terlipressin or high dose somatostatin/octreotide when usual dose somatostatin/octreotide fail to achieve hemostasis in patients with acute variceal bleeding.

NCT ID: NCT02256046 Recruiting - Cirrhosis Clinical Trials

Predictive Factors and Outcome of Esophageal Ulcers After Endoscopic Treatment of Esophageal Varices

Start date: August 2014
Phase: N/A
Study type: Interventional

Aim of this thesis is to predict the incidence of esophageal ulcer bleeding after endoscopic management of esophageal varices. This study will be in the department of Tropical Medicine and Infectious Diseases, Tanta University, in at least six months in the period from august 2014 to march 2015 or until the target number of patients reached whichever is longer.

NCT ID: NCT02119884 Completed - Clinical trials for Gastric and Esophageal Varices

Hemodynamic Effects of Terlipressin and High Dose Octreotide

HEofT&O
Start date: February 2014
Phase: Phase 4
Study type: Interventional

The purpose of the study is to find patients's response to terlipressin and octreotide during hepatic venous pressure gradient measurement by observing portal and systemic hemodynamics.

NCT ID: NCT02115061 Recruiting - Gastric Varices Clinical Trials

Gastric Varices Treatment: Coil + Cyanoacrylate Versus Cyanoacrylate

Start date: August 2013
Phase: Phase 1
Study type: Interventional

The purpose of the spring is to maintain the cyanoacrylate polymer of the gastric varix, forming a conglomerate spring-cyanoacrylate, and thus preventing their migration to the adhesive embolism. The introduction of the spring is held by a echo-guided puncture. The window can be puncture through the distal esophagus or directly in the gastric varix via retroflexion to the fundus. Another advantage of this technique is its use in the presence of bleeding, when large amounts of blood in the stomach hinders the injection of the cyanoacrylate, by pricking the distal esophagus that difficulty decreases. The first study of this technique was performed by Binmoeller et al (21) and had good results with 100% hemostasis and low rebleeding rate (16%), but more studies are needed to prove the safety and efficacy of this technique.

NCT ID: NCT02037659 Completed - Gastric Varices Clinical Trials

Dermabond Treatment for Gastric Variceal Bleeding

Start date: December 2012
Phase:
Study type: Observational [Patient Registry]

The purpose of having a database is to collect data related to endoscopic ultrasound procedures performed by Indiana University EUS physicians; specifically, for the treatment of gastric variceal bleeding This data will be used for research purposes only to determine the clinical impact of endoscopic ultrasound treatment of gastric variceal bleeding. The physicians will also be able to better understand the patient's condition and disease process that may lead to improved standard of care and improved patient management.

NCT ID: NCT01970748 Recruiting - Clinical trials for Hepatocellular Carcinoma

Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices

P-HCC
Start date: August 2009
Phase: Phase 4
Study type: Interventional

Randomized comparison within the endoscopic esophageal varices ligation versus non-selective beta-blocker in the primary prevention of esophageal variceal bleeding in patients with HCC.

NCT ID: NCT01923064 Completed - Portal Hypertension Clinical Trials

Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric Varices

Start date: October 2013
Phase: N/A
Study type: Interventional

The purpose of this randomized study to compare effect of endoscopic injection of a mixture of cyanoacrylate and lipiodol versus cyanoacrylate and lauromacrogol in gastric varices.

NCT ID: NCT01893541 Completed - CIRRHOSIS Clinical Trials

PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES?

Start date: June 2008
Phase: Phase 4
Study type: Interventional

This prospective randomized controlled trial will compare endoscopic band ligation (EBL) with propranolol and EBL alone in primary prophylaxis of variceal bleeding among cirrhotic patients with high-risk varices.

NCT ID: NCT01851564 Completed - Clinical trials for Acute Bleeding Esophageal Varices

RCT of Stent Versus Standard Therapy in Oesophageal Variceal Haemorrhage

SOV
Start date: August 2012
Phase: N/A
Study type: Interventional

The mortality rates from Acute Variceal Haemorrhage remain significant and first line therapy may fail in 15-25% of patients. The self-expandable metal stent has been described in case series as having a very high efficacy at control of haemorrhage from oesophageal varices when used as rescue therapy. This randomised controlled trial aims to assess for any potential superiority of the stent over 'standard' endoscopic techniques as primary or rescue therapy for bleeding oesophageal varices.

NCT ID: NCT01851252 Completed - Cirrhosis Clinical Trials

MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy

Start date: October 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the effect on the (carbon 13 labelled(13C)-Methacetin Breath Test (MBT) of i.v. propranolol, a non-selective beta blocker (NSBB) following initial administration and after chronic use of each of these agents. The correlation of the MBT with Hepatic Venous Pressure Gradient (HVPG) measurement before and after treatment will be assessed. Additionally, the MBT measurements following 60 days of therapy will be compared to the first MBT measurement and to the second MBT measurement, post HVPG. Each patient's subsequent MBT measurement will be compared to his previous MBT results in order to determine his/her response to therapy.